Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

ACCP Position Paper On Genetic Tests Advertised Directly To The Consumer
Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers" response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, according to a position paper from the American College of Clinical Pharmacology (ACCP) to be published in the August 2009 issue of the Journal of Clinical Pharmacology. The journal is published on behalf of the ACCP by SAGE. Don't forget to buy zoloft online no prescription.

CMA Supports Senate Move To Expand Health Care Coverage Access To A Doctor Must Be Protected
The California Medical Association applauded the U.S. Senate Finance Committee today for producing a thoughtful analysis of ways to expand the nation"s health care coverage. The committee"s paper, titled "Expanding Health Care Coverage: Proposals to Provide Affordable Coverage to All Americans," includes certain market reforms that all participating health plans would be required to participate in.

generic viagra online


News of the day
Kai Sensors Receives FDA Clearance For Its Wireless, Non-Contact Respiratory Device
Hawaii-based Kai Sensors announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kai Sensors Non-Contact Respiratory Rate Spot Check, also called the Kai RSpot. The 510(k) clearance allows Kai Sensors to market the Kai RSpot to physicians, hospitals, and clinics.
Health Insurance

AbbeyMoor Medical Receives FDA Approval For Design Improvements To The Spanner(TM) Prostatic Stent

AbbeyMoor Medical Inc., a developer and manufacturer of medical devices for the management and treatment of prostatic obstruction, announced that it has received PMA approval from the US Food and Drug Administration (FDA) for design changes to their flagship product, The Spanner(TM) Prostatic Stent. "These changes are aimed at further improving patient comfort over the current highly accepted levels," said Darren Cook, director of marketing with the company. "Our goal is to hear an even greater percentage of our patient"s state that they are not aware of the device"s presence." According to Mark Whalen, VP of product development with the company, "The approved changes to the device result in a significant increase in flexibility over the current Spanner design with no impact to the ease of delivery and removal of the device." The Spanner is a temporary prostatic stent designed to aid men who are experiencing difficulty in urination due to prostatic obstruction. Device placement can be performed in a physician office and does not require cystoscopy or anesthesia for placement. The Spanner is an alternative to indwelling catheterization, intermittent catheterization, or the use of a suprapubic tube in some patients. About AbbeyMoor Medical AbbeyMoor Medical is a privately held company that develops innovative medical devices focused on the management and treatment of male voiding dysfunction. The company"s initial focus is on the development and commercialization of The Spanner. AbbeyMoor Medical, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009